Your browser doesn't support javascript.
loading
Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial).
Garcia-Tejedor, Amparo; Ortega-Exposito, Carlos; Salinas, Sira; Luzardo-González, Ana; Falo, Catalina; Martinez-Pérez, Evelyn; Pérez-Montero, Héctor; Soler-Monsó, M Teresa; Bajen, Maria-Teresa; Benitez, Ana; Ortega, Raul; Petit, Anna; Guma, Anna; Campos, Miriam; Plà, Maria J; Pernas, Sonia; Peñafiel, Judith; Yeste, Carlos; Gil-Gil, Miguel; Guedea, Ferran; Ponce, Jordi; Laplana, Maria.
Afiliação
  • Garcia-Tejedor A; Department of Gynaecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Ortega-Exposito C; Department of Gynaecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Salinas S; Rehabilitation Service, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Luzardo-González A; Rehabilitation Service, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Falo C; Department of Medical Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Martinez-Pérez E; Department of Radiation Oncology, Multidisciplinary Breast Cancer Unit. Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Pérez-Montero H; Department of Radiation Oncology, Multidisciplinary Breast Cancer Unit. Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Soler-Monsó MT; Department of Pathology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Bajen MT; Department of Nuclear Medicine, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Benitez A; Department of Nuclear Medicine, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Ortega R; Department of Radiology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Petit A; Department of Pathology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Guma A; Department of Radiology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Campos M; Department of Gynaecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Plà MJ; Department of Gynaecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Pernas S; Department of Medical Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Peñafiel J; Biostatistics Unit, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Yeste C; Degree in Biology, Monitoring, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Gil-Gil M; Department of Medical Oncology, Multidisciplinary Breast Cancer Unit, Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Guedea F; Department of Radiation Oncology, Multidisciplinary Breast Cancer Unit. Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Ponce J; Department of Gynaecology, Multidisciplinary Breast Cancer Unit, Hospital Universitari Bellvitge, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
  • Laplana M; Department of Radiation Oncology, Multidisciplinary Breast Cancer Unit. Institut Català d'Oncología, Instituto de Investigación Biomédica de Bellvitge, Barcelona, Spain.
Front Oncol ; 13: 1184021, 2023.
Article em En | MEDLINE | ID: mdl-37621686
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline Idioma: En Ano de publicação: 2023 Tipo de documento: Article